Navigation Links
Scleroderma Cure Still In Oscillation

According to a recent study, an old drug promises to slow down the progress of the dreadful autoimmune disease scleroderma or systemic sclerosis//.

About 3,00,000 Americans were found to be affected by the fatal disease Scleroderma, which destroys our system by hardening and thickening the skin and in many times it completely damages the lungs and other related organs. Nearly 80% of affected people have lung damaged more often it includes women only.

When comparing the benefits with after effects of a usual drug named cyclophosphamide, or Cytoxan, used to treat cancer and some autoimmune disorders, only minimum benefits were evidenced.

The study authors reported that 158 scleroderma patients from the country’s hospital were assigned at random into 2 groups, which includes experimental group (taking Cytoxan pills) and control group (taking only dummy pills) 1 per day for a period of 1 year. Throughout the year they were monitered, and the results show only a little improvement in using Cytoxan group of drugs although there seems a statistically significant difference – said Dr. Philip J. Clements, a rheumatologist at the University of California, Los Angeles, who was a co-author of the study.

One among the adverse effects of using Cytoxan group of drugs was low white blood cell count, says author.

Dr. Clements reported in an interview that beyond many studies Cytoxan with little side effects for scleroderma patients only proves in part to benefit scleroderma patients with lung damage.

Since having adverse effects in the long-term use of the drug, researchers urged to carry out a follow up of this study in a fast rate.


'"/>




Page: 1

Related medicine news :

1. Cancer Drug to Treat Scleroderma Lung Disease
2. Link between C-section Delivery and Stillbirth
3. Estimates For Number Of HIV/AIDS Deaths In India Still Not Available
4. People Still Neglect To Use Sunscreen In Spite Of Cancer Warnings
5. Past President Narayanans Condition Still Critical
6. LASIK Treatments Still To Reach Common Man
7. Hurricane Hangover: Katrina Still Haunts
8. Tuberculosis Is Still A Major Health Threat In Africa
9. Despite More Studies Researchers Are Still Confound With ADHD
10. Children Are Exercising Much Harder, But Are Still Obese
11. Study Shows That More Than 3 Million Stillbirths Occur Worldwide Every Year
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/19/2017)... ... January 19, 2017 , ... Wells ... facility enhancement of their 503A compounding pharmacy located in Ocala, Florida. , ... physicians and patients throughout the United States for high-quality human anti-aging and ...
(Date:1/19/2017)... ... January 19, 2017 , ... This month, the CEO and ... name of their drug rehab center in Delray Beach, Florida has been changed from ... only stars such as Philip Seymour Hoffman and Chris Farley are dying from heroin ...
(Date:1/19/2017)... , ... January 19, 2017 , ... WhoHaha , ... up with the American Heart Association (AHA) to produce a three-part video series that ... will debut as part of the launch of AHA’s Healthy For Good™ movement, which ...
(Date:1/19/2017)... ... January 19, 2017 , ... Cosmetic Town, an online ... procedures in order to make it easier for their readers to get the information ... they impact as well as the techniques used on those particular areas. , “We ...
(Date:1/19/2017)... , ... January 19, 2017 , ... ... and development solutions for drugs, biologics and consumer health products, today announced that ... with Gattefossé, the leader in innovative excipients and drug delivery solutions to health ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Calif. , Jan. 19, 2017  Abaxis, Inc. ... manufacturing point-of-care blood analysis instruments and consumables for the ... call to discuss its financial results for the third ... call will be at 4:15 p.m. ET on Thursday, ... for the third quarter fiscal year 2017 after the ...
(Date:1/19/2017)... , Jan. 19, 2017  Sensus Healthcare, ... device company specializing in the treatment of non-melanoma ... keloids, with superficial radiation therapy, today announced that ... year 2016 financial results on Thursday, February 2, 2017 ... will hold a conference call with the investment ...
(Date:1/19/2017)... , January 19, 2017 ... announced that the U.S. Food and Drug Administration (FDA) ... a New Drug Application (NDA) for SHP465, a long-acting, ... as a potential once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). ... or around June 20, 2017, the designated Prescription Drug ...
Breaking Medicine Technology: